-
Report: Red Cross Spent 25 Percent Of Haiti Donations On Internal Expenses
The report also says the charity's top officials stonewalled congressional investigators and released incomplete information about its Haiti program to the public. It concludes "there are substantial and fundamental concerns about [the Red Cross] as an organization."The report also says the charity's top officials stonewalled congressional investigators and released incomplete information about its Haiti program to the public.
- Categories
- Health Care
- Region
- Latin America
-
‘Disease outbreak guarantees’—A proposed mechanism for enhancing public health capacity
The possible path to offering disease outbreak guarantees is an idea being posed by two global health researchers who suggest that a mechanism for establishing such an instrument could be tied to public health investments.
- Categories
- Health Care
-
New Tool to Diagnose Zika
A Boston University researcher is on the team that created a prototype for a simple new test.
- Categories
- Health Care
-
The Economics of Antibiotic Resistance
The business model for developing new antibiotics is broken, researchers say. The question is, can we make a new one that works?
- Categories
- Health Care
- Tags
- public health
-
In the lab: six innovations scientists hope will end malaria
After being abandoned as too ambitious in 1969, global plans to eliminate malaria are back on the agenda, with financial backing from the world's richest couple, Bill and Melinda Gates, and U.S. President Barack Obama.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- research
-
Analytical chemists schooled on drug development
Glaxo Smith Kline (GSK) Pharmaceutical Company has started a one week training workshop for African analytical chemists to equip them with practical skills in Gas Chromatography-Mass Spectrometry (GC-MS).
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
‘There’s no point giving free cancer drugs to Africa’
Giving out free cancer drugs would not help the poorest parts of Africa, the head of pharmaceutical giant AstraZeneca has told the BBC.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- public health
-
GHIT Fund partners with 10 new global cos to expand investment in R&D for neglected diseases worldwide
The Global Health Innovative Technology Fund (GHIT Fund) welcomed ten new partnerships that include major global pharmaceutical and biotechnology companies—collaborations that will expand investments into research and development (R&D) for neglected diseases worldwide.
- Categories
- Health Care, Technology
- Region
- Asia Pacific
- Tags
- innovation
Subscribe to Our Weekly Newsletter, "NextBillion Notes"
Published each Wednesday, our e-newsletter features NextBillion's latest original articles, along with a selection of news, jobs, bizdev opportunities and events from our recent coverage — and regular conference ticket giveaways.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.